Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 20/20 | 0.73 |
| ▸ | GRIN1 | Q05586 | 15/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22775595 | 1.00 | GRIN2B (0.73) | GRIN2BGRIN1CYP2C9KCNH2 | |
| Trifluoroacetic Acid SCHEMBL29550144 | 0.97 | GRIN2B (0.70) | GRIN2BGRIN1CYP2C9KCNH2 | |
| SCHEMBL29550496 | 0.93 | GRIN2B (0.67) | GRIN2BGRIN1CYP2C9KCNH2 | |
| SCHEMBL22802741 | 0.93 | GRIN2B (0.67) | GRIN2BGRIN1CYP2C9KCNH2 | |
| SCHEMBL29550191 | 0.93 | GRIN2B (0.63) | GRIN2BGRIN1CYP2C9KCNH2 | |
| SCHEMBL22775294 | 0.93 | GRIN2B (0.63) | GRIN2BGRIN1CYP2C9KCNH2 | |
| SCHEMBL22802738 | 0.92 | GRIN2B (0.62) | GRIN2BGRIN1CYP2C9KCNH2 | |
| SCHEMBL29550434 | 0.92 | GRIN2B (0.62) | GRIN2BGRIN1CYP2C9KCNH2 | |
| SCHEMBL22775639 | 0.91 | GRIN2B (0.61) | GRIN2BGRIN1CYP2C9KCNH2 | |
| SCHEMBL29550361 | 0.91 | GRIN2B (0.61) | GRIN2BGRIN1CYP2C9KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3983075-A1 | SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | Janssen Pharmaceutica NV (BE) | 2022-04-20 | — | — | EP | claimed |
| EP-3983075-A1 | SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | Janssen Pharmaceutica NV (BE) | 2022-04-20 | — | — | EP | disclosed |